— Know what they know.
Not Investment Advice

TSHA NASDAQ

Taysha Gene Therapies, Inc.
1W: -12.1% 1M: -17.6% 3M: +17.9% YTD: +5.5% 1Y: +89.1% 3Y: +700.6% 5Y: -73.5%
$5.49
-0.05 (-0.90%)
 
Weekly Expected Move ±8.1%
$5 $5 $6 $6 $7
NASDAQ · Healthcare · Biotechnology · Alpha Radar Sell · Power 34 · $1.4B mcap · 236M float · 1.19% daily turnover · Short 47% of daily vol

🏦 Institutional Activity

Latest: Q1 2026
227
Institutions Holding
+6 vs prior
68.9%
Ownership
-38.47%
30 New
60 Increased
100 Reduced
58 Closed

👔 Insider Trades

22 records
Date Name Title Type Shares Price Value Filing
2026-02-04 Alam Kamran officer: chief financial officer S-Sale 1,655 $4.52 $7K Filing
2026-01-26 Alam Kamran officer: chief financial officer S-Sale 23,849 $4.61 $110K Filing
2026-01-26 Nagendran Sukumar officer: president and head of r&d S-Sale 26,918 $4.61 $124K Filing
2026-01-26 Nolan Sean P. officer: chief executive officer S-Sale 41,312 $4.61 $190K Filing
2026-01-23 Alam Kamran officer: chief financial officer S-Sale 78,968 $4.75 $375K Filing
2026-01-23 Nagendran Sukumar officer: president and head of r&d S-Sale 89,132 $4.75 $423K Filing
2026-01-23 Nolan Sean P. officer: chief executive officer S-Sale 136,789 $4.75 $650K Filing
2026-01-12 Alam Kamran officer: chief financial officer A-Grant/Award 359,000 $— $0 Filing
2026-01-12 Nagendran Sukumar officer: president and head of r&d S-Sale 200,000 $4.71 $942K Filing
2026-01-12 Nagendran Sukumar officer: president and head of r&d A-Grant/Award 427,000 $— $0 Filing
2026-01-12 Nolan Sean P. officer: chief executive officer A-Grant/Award 1,008,000 $— $0 Filing
2025-12-01 Nagendran Sukumar officer: president and head of r&d S-Sale 260,047 $4.51 $1.2M Filing
2025-11-28 Nagendran Sukumar officer: president and head of r&d S-Sale 110,125 $4.75 $523K Filing
2025-09-10 Nagendran Sukumar officer: president and head of r&d S-Sale 200,000 $3.23 $646K Filing
2025-08-21 Alam Kamran officer: chief financial officer S-Sale 54,491 $2.85 $155K Filing
2025-08-21 Nagendran Sukumar officer: president and head of r&d S-Sale 57,054 $2.85 $163K Filing
2025-06-02 Donenberg Phillip B. director A-Grant/Award 56,623 $— $0 Filing
2025-06-02 Long Alison S director A-Grant/Award 56,623 $— $0 Filing
2025-06-02 Sepp-Lorenzino Laura director A-Grant/Award 56,623 $— $0 Filing
2025-06-02 Stalfort John A III director A-Grant/Award 56,623 $— $0 Filing
2025-05-30 Manning Paul B 10% owner P-Purchase 750,000 $2.75 $2.1M Filing
2025-03-11 Alam Kamran officer: chief financial officer F-Tax Withholding 29,843 $1.69 $50K Filing

🏛️ Congressional Trades

0 records
Date Politician Chamber Type Amount Filing
No congressional trades found

🏦 Top Institutional Holders

20 holders
Holder Shares Value Date Reported Filing
RA CAPITAL MANAGEMENT, L.P. 23,555,648 $105M 2026-03-31 Filing
GOLDMAN SACHS GROUP INC 22,369,645 $100M +8,676,906 2026-03-31 Filing
Avoro Capital Advisors LLC 21,700,000 $97M 2026-03-31 Filing
BlackRock, Inc. 18,365,608 $82M -277,521 2026-03-31 Filing
FMR LLC 14,321,255 $64M +792,889 2026-03-31 Filing
RTW INVESTMENTS, LP 13,680,248 $61M -2,718,049 2026-03-31 Filing
STATE STREET CORP 11,209,078 $50M +418,994 2026-03-31 Filing
VANGUARD CAPITAL MANAGEMENT LLC 10,231,502 $46M +10,231,502 2026-03-31 Filing
Octagon Capital Advisors LP 8,859,911 $40M 2026-03-31 Filing
Siren, L.L.C. 8,829,913 $39M -1,300,000 2026-03-31 Filing
Polar Capital Holdings Plc 5,654,340 $25M -2,277,063 2026-03-31 Filing
GEODE CAPITAL MANAGEMENT, LLC 5,531,955 $25M +144,929 2026-03-31 Filing
GordonMD Global Investments LP 737,550 $22M -593,351 2026-03-31 Filing
ADAR1 Capital Management, LLC 2,979,429 $13M +483,620 2026-03-31 Filing
HEALTHCARE OF ONTARIO PENSION PLAN TRUST 2,883,301 $13M -838,699 2026-03-31 Filing
BARCLAYS PLC 2,812,010 $11M -2,726,991 2026-03-31 Filing
VANGUARD PORTFOLIO MANAGEMENT LLC 2,022,498 $9M +2,022,498 2026-03-31 Filing
RICE HALL JAMES & ASSOCIATES, LLC 1,944,671 $9M +674,026 2026-03-31 Filing
NORTHERN TRUST CORP 1,814,318 $8M +576,331 2026-03-31 Filing
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 1,808,599 $8M -94,379 2026-03-31 Filing

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms